Feds Investigating Prescription Drug Price Increases
Nelson has been critical of the $80 billion agreement. In fact, he called for a larger share of savings from the pharmaceutical manufacturers during a Senate Finance Committee hearing in September.
In an amendment, he proposed that the pharmaceutical industry "surrender a financial windfall" it gets on drugs sold to Medicare patients who also qualify for Medicaid, called "dual eligibles." The amendment, which Nelson said would saved taxpayers an estimated $106 billion over 10 years, was based on estimates provided by the Congressional Budget Office. It was defeated in a 13-10 vote at that time.
Janice Simmons is a senior editor and Washington, DC, correspondent for HealthLeaders Media Online. She can be reached at email@example.com.
- Technology Lights Up Health Innovation Forum
- Few Winners Among MSSP Participants
- NCQA Releases Annual Health Plan Rankings
- How much does that x-ray cost? You can find out in NH
- Data Points to Boom in Private HIX
- When a hospital closes
- Anthem Blue Cross, 7 CA Health Systems Create New Challenger, Business Model
- Administration: 7.3M now enrolled in Obamacare
- EHR Systems 'Immature, Costly,' AMA Says
- US health system among least efficient before Obamacare